Extensive Portfolio Sandoz Canada offers over 700 medicines across multiple therapeutic areas, presenting a broad footprint for cross-sell opportunities to pharmacists, hospitals, and clinics seeking affordable generics and biosimilars.

Biosimilar Momentum Recent launches in biosimilars such as Enzeevu and Hyrimoz, plus ongoing pipeline activities, indicate growing demand for affordable biologic treatments and potential partnerships to expand access and market share in Canada.

Strategic Partnerships Recognized as a trusted partner to local pharmacists and healthcare institutions with a focus on reliable supply, presenting opportunities for collaboration on formulary inclusion, preferred supplier programs, and differentiation through service quality.

Sustainability Alignment Packaging sourcing through FSC certification and environmental initiatives position Sandoz Canada as a sustainability-conscious supplier, opening doors for hospitals and manufacturers prioritizing green procurement and ESG reporting.

Growth Indicators Leadership awards and expansion activity signal a growth trajectory and potential for channel expansion, including partnerships for new product launches, tender participation, and accelerated market penetration in Canadian healthcare settings.